The role of LIMK1 and cofilin in AD is complicated by context-dependent regulatory mechanisms, with observed differences in pathway activity likely influenced by factors such as disease stage, neuronal type, and local concentrations of neurotoxic proteins. The gene discussed is CFL1; the disease is Alzheimer disease.